Nizoral Stada Arzneimittel (Ketoconazole)

Ketoconazole, the active ingredient in Nizoral Stada Arzneimittel, is an azole antifungal presented as a topical formulation for cutaneous use. It treats fungal skin conditions such as dermatophyte infections, seborrheic dermatitis and tinea versicolor in adults and children when prescribed by a healthcare professional.

GNH USA supplies Nizoral Stada Arzneimittel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory support for cross‑border distribution. This enables reliable access to the product across diverse markets.

Ketoconazole is used topically to treat fungal skin disorders by inhibiting the growth of dermatophytes and yeasts.

- Dermatophyte infections: reduces fungal proliferation and promotes resolution of skin lesions. - Seborrheic dermatitis: controls Malassezia overgrowth, decreasing scaling and erythema. - Tinea versicolor: eliminates the causative yeast, restoring normal skin pigmentation.

Topical ketoconazole may cause local skin reactions, ranging from mild irritation to rare severe events.

Common Side Effects: - Itching: mild pruritus at the application site. - Burning sensation: transient heat or stinging feeling. - Redness: localized erythema. - Dryness: skin flaking or scaling.

Serious or Rare Side Effects: - Contact dermatitis: allergic reaction with swelling and intense itching. - Skin ulceration: breakdown of skin integrity. - Severe hypersensitivity: systemic rash, fever, or angioedema. - Photosensitivity: increased skin sensitivity to sunlight.

When using ketoconazole topical preparations, consider the following precautions to ensure safe and effective therapy.

- Application area: limit use to affected skin and avoid mucous membranes. - Duration of therapy: follow prescriber’s recommended treatment length; prolonged use may increase irritation risk. - Concomitant skin products: avoid using other topical irritants or corticosteroids unless advised. - Pregnancy and lactation: use only if the benefit outweighs potential risk, after medical consultation. - Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Ketoconazole can interact with other topical agents and systemic medications that affect cytochrome P450 enzymes.

Major Interactions (Avoid): - Systemic azoles: concurrent systemic antifungal therapy may increase toxicity. - Warfarin: topical ketoconazole may enhance anticoagulant effect when used over large areas.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may reduce antifungal efficacy if applied simultaneously. - Sunscreens: may increase risk of photosensitivity reactions. - Other P450 substrates: extensive skin application could affect systemic absorption of drugs metabolized by CYP enzymes.